Want to see HK:0570 full AI Analyst Report?
0570 Stock Chart & Stats
HK$2.16
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$2.16
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.32 - HK$2.68
Previous CloseN/A
Volume9.47M
Average Volume (3M)51.13M
Market Cap
HK$6.80B
Enterprise ValueHK$4.79B
Total Cash (Recent Filing)HK$5.16B
Total Debt (Recent Filing)HK$2.49B
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.66%
Share Statistics
EPS (TTM)-0.07
Shares Outstanding5,035,802,000
10 Day Avg. Volume46,853,920
30 Day Avg. Volume51,130,115
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.46
Price to Sales (P/S)0.64
P/FCF Ratio4.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.14
Revenue Forecast (FY)HK$14.38B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetA lower leverage profile and falling total debt reduce refinancing and liquidity risk, giving management time to execute a recovery. A conservative balance sheet increases long-term financial flexibility to fund R&D, product rollouts or dividends without forcing dilutive financing.
Strong Recent Cash GenerationSustained positive operating and free cash flow in the last two years supports ongoing operations, dividend payments and debt reduction even with accounting losses. Durable cash conversion strengthens solvency and funds strategic priorities without reliance on capital markets.
High Dividend YieldA materially high yield can signal disciplined shareholder returns and attract income-focused investors if supported by cash flows. If management maintains payouts alongside conservative leverage, dividends provide a structural floor to returns over the medium term.
Bears Say
Deteriorating ProfitabilityThe shift to a net loss and sustained margin compression indicate structural pressure on core earnings. Without margin recovery or clear cost fixes, the company may struggle to rebuild returns on capital, limiting its ability to reinvest and compound shareholder value.
Inconsistent Revenue TrendsIrregular top-line performance signals unstable demand or pricing and makes forecasting and capacity planning harder. Persistent revenue volatility undermines margin recovery efforts and raises execution risk for product strategy and market positioning over the medium term.
Volatile Cash Flow HistoryAlthough recent cash generation is strong, historical volatility and recent sharp FCF swings raise concerns about durability. If cash flows revert or become cyclical, dividend sustainability and debt servicing could be threatened, forcing cuts or asset sales.
China Traditional Chinese Medicine Holdings Co News
0570 FAQ
What was China Traditional Chinese Medicine Holdings Co Ltd’s price range in the past 12 months?
China Traditional Chinese Medicine Holdings Co Ltd lowest stock price was HK$1.32 and its highest was HK$2.68 in the past 12 months.
What is China Traditional Chinese Medicine Holdings Co Ltd’s market cap?
China Traditional Chinese Medicine Holdings Co Ltd’s market cap is HK$6.80B.
When is China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date?
China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 56 days.
How were China Traditional Chinese Medicine Holdings Co Ltd’s earnings last quarter?
China Traditional Chinese Medicine Holdings Co Ltd released its earnings results on Mar 20, 2026. The company reported -HK$0.051 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.051.
Is China Traditional Chinese Medicine Holdings Co Ltd overvalued?
According to Wall Street analysts China Traditional Chinese Medicine Holdings Co Ltd’s price is currently Overvalued.
Does China Traditional Chinese Medicine Holdings Co Ltd pay dividends?
China Traditional Chinese Medicine Holdings Co Ltd pays a Notavailable dividend of HK$0.086 which represents an annual dividend yield of 3.66%. See more information on China Traditional Chinese Medicine Holdings Co Ltd dividends here
What is China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate?
China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Traditional Chinese Medicine Holdings Co Ltd have?
China Traditional Chinese Medicine Holdings Co Ltd has 5,035,802,000 shares outstanding.
What happened to China Traditional Chinese Medicine Holdings Co Ltd’s price movement after its last earnings report?
China Traditional Chinese Medicine Holdings Co Ltd reported an EPS of -HK$0.051 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.529%.
Which hedge fund is a major shareholder of China Traditional Chinese Medicine Holdings Co Ltd?
Currently, no hedge funds are holding shares in HK:0570
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Traditional Chinese Medicine Holdings Co Ltd
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
Technical Analysis
Guangzhou Baiyunshan Pharmaceutical Holdings Company
―
Wai Yuen Tong Medicine Holdings Limited
―
Grand Pharmaceutical Group Limited
―
Golden Throat Holdings Group Co Ltd
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Options Prices
Currently, No data available
---